vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and Magnolia Oil & Gas Corp (MGY). Click either name above to swap in a different company.
Magnolia Oil & Gas Corp is the larger business by last-quarter revenue ($317.6M vs $168.4M, roughly 1.9× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -2.7%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs -0.3%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Imperial Oil Limited is a Canadian petroleum company. It is Canada's second-largest integrated oil company that is also occasionally known as Imperial Esso. It is majority-owned by American oil company ExxonMobil, with a 69.6% ownership stake in the company. It is a producer of crude oil, diluted bitumen, and natural gas. Imperial Oil is one of Canada's major petroleum refiners and petrochemical producers. It supplies Esso-brand service stations.
ESPR vs MGY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $317.6M |
| Net Profit | — | $68.8M |
| Gross Margin | — | — |
| Operating Margin | 50.6% | 29.6% |
| Net Margin | — | 21.6% |
| Revenue YoY | 143.7% | -2.7% |
| Net Profit YoY | — | -19.7% |
| EPS (diluted) | $0.32 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $317.6M | ||
| Q3 25 | $87.3M | $324.9M | ||
| Q2 25 | $82.4M | $319.0M | ||
| Q1 25 | $65.0M | $350.3M | ||
| Q4 24 | $69.1M | $326.6M | ||
| Q3 24 | $51.6M | $333.1M | ||
| Q2 24 | $73.8M | $336.7M | ||
| Q1 24 | $137.7M | $319.4M |
| Q4 25 | — | $68.8M | ||
| Q3 25 | $-31.3M | $75.5M | ||
| Q2 25 | $-12.7M | $78.1M | ||
| Q1 25 | $-40.5M | $102.9M | ||
| Q4 24 | — | $85.6M | ||
| Q3 24 | $-29.5M | $99.8M | ||
| Q2 24 | $-61.9M | $95.6M | ||
| Q1 24 | $61.0M | $85.1M |
| Q4 25 | 50.6% | 29.6% | ||
| Q3 25 | -11.4% | 31.2% | ||
| Q2 25 | 8.6% | 33.8% | ||
| Q1 25 | -34.0% | 38.8% | ||
| Q4 24 | -6.4% | 38.0% | ||
| Q3 24 | -31.0% | 38.7% | ||
| Q2 24 | 3.5% | 39.9% | ||
| Q1 24 | 52.5% | 39.0% |
| Q4 25 | — | 21.6% | ||
| Q3 25 | -35.9% | 23.2% | ||
| Q2 25 | -15.4% | 24.5% | ||
| Q1 25 | -62.2% | 29.4% | ||
| Q4 24 | — | 26.2% | ||
| Q3 24 | -57.2% | 30.0% | ||
| Q2 24 | -83.9% | 28.4% | ||
| Q1 24 | 44.3% | 26.6% |
| Q4 25 | $0.32 | — | ||
| Q3 25 | $-0.16 | — | ||
| Q2 25 | $-0.06 | — | ||
| Q1 25 | $-0.21 | — | ||
| Q4 24 | $-0.14 | — | ||
| Q3 24 | $-0.15 | — | ||
| Q2 24 | $-0.33 | — | ||
| Q1 24 | $0.34 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $266.8M |
| Total DebtLower is stronger | — | $393.3M |
| Stockholders' EquityBook value | $-302.0M | $2.0B |
| Total Assets | $465.9M | $2.9B |
| Debt / EquityLower = less leverage | — | 0.20× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $266.8M | ||
| Q3 25 | $92.4M | $280.5M | ||
| Q2 25 | $86.1M | $251.8M | ||
| Q1 25 | $114.6M | $247.6M | ||
| Q4 24 | $144.8M | $260.0M | ||
| Q3 24 | $144.7M | $276.1M | ||
| Q2 24 | $189.3M | $275.7M | ||
| Q1 24 | $226.6M | $399.3M |
| Q4 25 | — | $393.3M | ||
| Q3 25 | — | $393.1M | ||
| Q2 25 | — | $392.9M | ||
| Q1 25 | — | $392.7M | ||
| Q4 24 | — | $392.5M | ||
| Q3 24 | — | $394.8M | ||
| Q2 24 | — | $394.1M | ||
| Q1 24 | — | $393.5M |
| Q4 25 | $-302.0M | $2.0B | ||
| Q3 25 | $-451.4M | $2.0B | ||
| Q2 25 | $-433.5M | $2.0B | ||
| Q1 25 | $-426.2M | $2.0B | ||
| Q4 24 | $-388.7M | $2.0B | ||
| Q3 24 | $-370.2M | $2.0B | ||
| Q2 24 | $-344.2M | $1.9B | ||
| Q1 24 | $-294.3M | $1.9B |
| Q4 25 | $465.9M | $2.9B | ||
| Q3 25 | $364.0M | $2.9B | ||
| Q2 25 | $347.1M | $2.9B | ||
| Q1 25 | $324.0M | $2.9B | ||
| Q4 24 | $343.8M | $2.8B | ||
| Q3 24 | $314.1M | $2.8B | ||
| Q2 24 | $352.3M | $2.8B | ||
| Q1 24 | $373.1M | $2.8B |
| Q4 25 | — | 0.20× | ||
| Q3 25 | — | 0.20× | ||
| Q2 25 | — | 0.20× | ||
| Q1 25 | — | 0.20× | ||
| Q4 24 | — | 0.20× | ||
| Q3 24 | — | 0.20× | ||
| Q2 24 | — | 0.21× | ||
| Q1 24 | — | 0.21× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $208.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | 3.03× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $208.4M | ||
| Q3 25 | $-4.3M | $247.1M | ||
| Q2 25 | $-31.4M | $198.7M | ||
| Q1 25 | $-22.6M | $224.5M | ||
| Q4 24 | $-35.0M | $222.6M | ||
| Q3 24 | $-35.3M | $217.9M | ||
| Q2 24 | $-7.2M | $269.4M | ||
| Q1 24 | $53.8M | $210.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-35.5M | — | ||
| Q2 24 | $-7.3M | — | ||
| Q1 24 | $53.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -68.7% | — | ||
| Q2 24 | -9.9% | — | ||
| Q1 24 | 39.0% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | 3.03× | ||
| Q3 25 | — | 3.27× | ||
| Q2 25 | — | 2.54× | ||
| Q1 25 | — | 2.18× | ||
| Q4 24 | — | 2.60× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | — | 2.82× | ||
| Q1 24 | 0.88× | 2.48× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
MGY
| Oil And Condensate | $215.6M | 68% |
| Natural Gas Reserves | $52.9M | 17% |
| Natural Gas Liquids Reserves | $49.1M | 15% |
